0,968  0,000  Aldose reductase substrate
0,960  0,001  NOS3 expression inhibitor
0,928  0,001  Alpha-N-acetylglucosaminidase inhibitor
0,861  0,002  Alcohol oxidase inhibitor
0,807  0,004  Hypoglycemic
0,805  0,005  GST A substrate
0,798  0,004  Aldehyde oxidase inhibitor
0,798  0,007  Antidiabetic
0,798  0,007  Cyclophilin D inhibitor
0,771  0,000  Mannitol 2-dehydrogenase inhibitor
0,696  0,001  Triose-phosphate isomerase inhibitor
0,705  0,011  Carcinogenic
0,662  0,003  Chelator
0,665  0,019  Teratogen
0,659  0,018  Embryotoxic
0,639  0,004  Interleukin 6 antagonist
0,633  0,007  5 Hydroxytryptamine release inhibitor
0,630  0,007  Skin irritative effect
0,631  0,008  Lipoprotein disorders treatment
0,631  0,009  Immunosuppressant
0,631  0,013  Radioprotector
0,620  0,004  Amylase inhibitor
0,609  0,004  Peroxidase inhibitor
0,609  0,006  Hypolipemic
0,614  0,013  Mutagenic
0,609  0,011  Cytostatic
0,606  0,009  Eye irritation, high
0,604  0,011  Hepatic disorders treatment
0,598  0,019  Cholesterol antagonist
0,581  0,002  NADH dehydrogenase inhibitor
0,581  0,004  Hematopoietic
0,584  0,013  Cardiovascular analeptic
0,586  0,016  5 Hydroxytryptamine release stimulant
0,577  0,008  Antiglaucomic
0,583  0,013  Immunomodulator
0,600  0,036  Caspase 9 stimulant
0,574  0,013  Cardioprotectant
0,554  0,004  Radiosensitizer
0,561  0,013  Ulceration
0,558  0,015  Inflammatory Bowel disease treatment
0,553  0,012  Metabolic disease treatment
0,544  0,003  Antineoplastic, alkylator
0,554  0,013  Antifungal
0,554  0,016  Histamine release inhibitor
0,555  0,018  Antipruritic, allergic
0,528  0,002  UDP-glucose 4-epimerase inhibitor
0,528  0,003  Carcinogenic, group 1
0,535  0,014  FMO1 substrate
0,523  0,002  Alcohol dehydrogenase substrate
0,521  0,005  VCAM1 expression inhibitor
0,523  0,007  Antiviral (HIV)
0,534  0,020  Chemoprotective
0,531  0,023  Vasodilator, peripheral
0,509  0,005  Antiviral (Influenza)
0,541  0,039  Antineoplastic (solid tumors)
0,512  0,014  Vasodilator, coronary
0,492  0,006  Antieczematic atopic
0,496  0,010  Antihypoxic
0,496  0,014  DNA synthesis inhibitor
0,486  0,005  GST P1-1 substrate
0,523  0,041  TNF expression inhibitor
0,493  0,012  UGT2B4 substrate
0,487  0,006  Antihypotensive
0,488  0,008  Hepatoprotectant
0,491  0,013  Antihypertriglyceridemic
0,478  0,005  Urolithiasis treatment
0,492  0,023  Sensitization
0,468  0,003  Phenylalanine 4-hydroxylase inhibitor
0,468  0,002  Phosphofructokinase-1 inhibitor
0,481  0,033  Stroke treatment
0,454  0,006  Antidote
0,449  0,003  Constipation treatment
0,447  0,003  Antifungal (Cryptococcus)
0,457  0,015  Vascular (periferal) disease treatment
0,450  0,017  Antidiabetic symptomatic
0,442  0,017  Vasodilator
0,506  0,085  Antiinflammatory
0,422  0,007  Muscular dystrophy treatment
0,412  0,003  Carbamoyl phosphate synthetase inhibitor
0,428  0,021  Renal disease treatment
0,443  0,038  Immunostimulant
0,430  0,027  Interleukin antagonist
0,446  0,043  GABA C receptor rho-3 antagonist
0,433  0,031  Antihypertensive
0,403  0,002  Plasmepsin I inhibitor
0,403  0,004  Succinate dehydrogenase inhibitor
0,428  0,030  UGT1A9 substrate
0,411  0,013  Antiviral (Herpes)
0,400  0,004  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,397  0,002  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,442  0,048  Atherosclerosis treatment
0,423  0,031  Antioxidant
0,403  0,011  GST M1-1 substrate
0,395  0,005  CNS active muscle relaxant
0,390  0,003  Mannose-6-phosphate isomerase inhibitor
0,391  0,005  Growth factor agonist
0,402  0,016  Abortion inducer
0,396  0,010  Antipruritic, non-allergic
0,425  0,040  Respiratory analeptic
0,397  0,013  Diuretic
0,420  0,040  Antihypercholesterolemic
0,383  0,007  Antidiarrheal
0,401  0,025  Cardiodepressant
0,402  0,027  Antipyretic
0,374  0,004  Excitatory amino acid transporter EAAC1 inhibitor
0,395  0,028  Superoxide dismutase inhibitor
0,399  0,032  Antidiabetic (type 2)
0,430  0,064  Antibacterial
0,368  0,005  Expectorant
0,370  0,009  Sepsis treatment
0,367  0,009  Diabetic nephropathy treatment
0,360  0,002  Alpha-mannosidase inhibitor
0,357  0,003  Biliverdin reductase inhibitor
0,356  0,002  Anesthetic inhalation
0,360  0,006  GABA C receptor agonist
0,371  0,020  Antiparkinsonian, rigidity relieving
0,411  0,060  CYP3A4 substrate
0,368  0,023  Wound healing agent
0,351  0,006  Hexokinase inhibitor
0,393  0,052  Antiallergic
0,339  0,002  Mannosidase inhibitor
0,339  0,003  Neuraminidase (influenza) inhibitor
0,340  0,004  Mucolytic
0,339  0,005  Antispirochetal
0,344  0,012  Antiviral (Influenza A)
0,385  0,054  Bone diseases treatment
0,374  0,044  Analeptic
0,334  0,005  Adenylate kinase inhibitor
0,360  0,031  UGT1A6 substrate
0,351  0,022  UGT1A4 substrate
0,338  0,009  Glutathione S-transferase substrate
0,342  0,014  Peptidyltransferase inhibitor
0,343  0,015  Skeletal muscle relaxant
0,343  0,015  Carcinogenic, group 3
0,337  0,010  Alkylator
0,369  0,044  CTGF expression inhibitor
0,340  0,015  Pneumotoxic
0,347  0,024  Anesthetic general
0,359  0,036  Chronic obstructive pulmonary disease treatment
0,331  0,009  Aldehyde dehydrogenase inhibitor
0,368  0,047  CYP1A2 substrate
0,330  0,010  Insulin secretagoues
0,344  0,024  Septic shock treatment
0,329  0,010  Acute respiratory distress syndrome (ARDS) treatment
0,320  0,001  Glucose-6-phosphate isomerase inhibitor
0,328  0,010  Cystic fibrosis treatment
0,410  0,092  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,324  0,008  Interleukin 1b antagonist
0,357  0,041  NOS2 expression inhibitor
0,321  0,007  Antiviral (Poxvirus)
0,328  0,016  Hair growth stimulant
0,348  0,041  Sodium/bile acid cotransporter inhibitor
0,360  0,054  CYP2D6 substrate
0,336  0,033  Interleukin agonist
0,349  0,046  Interleukin 2 agonist
0,339  0,036  Acute neurologic disorders treatment
0,301  0,003  Neuraminidase inhibitor
0,340  0,041  FMO3 substrate
0,306  0,009  Aldehyde oxidase substrate
0,300  0,005  UGT2B10 substrate
0,345  0,051  Antiosteoporotic
0,303  0,010  UGT2B9 substrate
0,314  0,021  Antiseptic
0,316  0,026  Tyrosine 3 hydroxylase inhibitor
0,301  0,011  Nitric-oxide synthase stimulant
0,298  0,010  Antitussive
0,290  0,003  Antidote, mercury
0,307  0,020  UGT1A3 substrate
0,305  0,019  Acaricide
0,288  0,003  Antidote, heavy metal
0,310  0,024  UGT2B7 substrate
0,348  0,065  Antithrombotic
0,288  0,009  Ferrochelatase inhibitor
0,281  0,004  Sphingomyelinase inhibitor
0,283  0,006  Selectin antagonist
0,305  0,030  Muscle relaxant
0,292  0,018  Antiparkinsonian, tremor relieving
0,283  0,009  Neuropathy treatment
0,289  0,017  Hemostatic
0,317  0,046  Antineoplastic (renal cancer)
0,310  0,040  Antiparasitic
0,308  0,039  Cyclic AMP phosphodiesterase inhibitor
0,287  0,018  Genotoxic
0,337  0,068  ICAM1 expression inhibitor
0,330  0,064  Calcium channel activator
0,296  0,032  RNA-directed DNA polymerase inhibitor
0,283  0,020  Phospholipase C inhibitor
0,283  0,022  Irritable Bowel syndrome treatment
0,272  0,012  MAP kinase kinase inhibitor
0,380  0,123  Alpha-glucosidase inhibitor
0,271  0,015  Renal failure treatment
0,257  0,002  Antiviral (Parainfluenza)
0,276  0,021  UGT2B15 substrate
0,267  0,013  Cell wall synthesis inhibitor
0,292  0,038  Gastrin inhibitor
0,258  0,006  Antirickettsial
0,256  0,006  Raynaud's phenomenon treatment
0,255  0,007  Glutamate dehydrogenase inhibitor
0,257  0,008  Catalase inhibitor
0,301  0,053  Flavin-containing monooxygenase substrate
0,295  0,048  5 Hydroxytryptamine uptake stimulant
0,285  0,039  UDP-glucuronosyltransferase substrate
0,253  0,008  Microtubule formation inhibitor
0,247  0,004  Glutamate decarboxylase inhibitor
0,283  0,041  MAP kinase kinase 2 inhibitor
0,254  0,018  Interleukin 1 antagonist
0,244  0,009  Histidine decarboxylase inhibitor
0,241  0,007  GABA C receptor antagonist
0,241  0,008  Antifibrinolytic
0,236  0,004  GST T1-1 substrate
0,237  0,005  Keratolytic
0,271  0,040  UGT1A1 substrate
0,269  0,039  Antihelmintic
0,246  0,017  Antianemic
0,305  0,077  Antineoplastic (brain cancer)
0,231  0,004  Acyl-CoA dehydrogenase inhibitor
0,231  0,005  Adenylate cyclase stimulant
0,234  0,009  HDL-cholesterol increasing
0,254  0,028  Anesthetic
0,249  0,024  Corneal wound healing stimulator
0,249  0,027  Protein kinase stimulant
0,259  0,039  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,326  0,106  CYP2C19 inhibitor
0,231  0,011  MAP kinase kinase 5 inhibitor
0,227  0,007  Creatine kinase inhibitor
0,226  0,007  Carcinogenic, group 2A
0,229  0,012  Arachidonic acid antagonist
0,219  0,004  HIV-1 protease inhibitor
0,288  0,075  Spasmolytic
0,234  0,021  Uterine stimulant
0,228  0,016  Carcinogenic, group 2B
0,215  0,004  Maillard reaction inhibitor
0,225  0,014  Antieczematic
0,212  0,003  Aconitate hydratase inhibitor
0,271  0,063  Proliferative diseases treatment
0,314  0,107  Antiobesity
0,247  0,040  Neurotrophic factor enhancer
0,227  0,022  Antihyperlipoproteinemic
0,307  0,102  CYP2C9 substrate
0,252  0,049  Sedative
0,207  0,005  Interferon agonist
0,208  0,007  GABA C receptor rho-1 antagonist
0,218  0,017  Aminopeptidase B inhibitor
0,241  0,040  Insulin sensitizer
0,244  0,043  P-glycoprotein inhibitor
0,277  0,077  CYP2C19 substrate
0,222  0,022  SULT1A3 substrate
0,231  0,032  Interferon gamma antagonist
0,210  0,011  Aldehyde dehydrogenase substrate
0,240  0,042  CYP2B6 inhibitor
0,242  0,044  Antiviral (West Nile virus)
0,211  0,014  Menstruation disorders treatment
0,267  0,071  DNA damaging
0,271  0,076  Antineurogenic pain
0,200  0,007  Aminopeptidase I inhibitor
0,235  0,042  Antimutagenic
0,263  0,073  Cardiotonic
0,223  0,034  Melanin inhibitor
0,269  0,080  Insulysin inhibitor
0,192  0,004  Ca2+-transporting ATPase inhibitor
0,192  0,005  UGT2B11 substrate
0,241  0,054  Chemopreventive
0,201  0,014  Mediator release inhibitor
0,211  0,024  Cholesterol synthesis inhibitor
0,206  0,021  Toll-Like receptor 2 antagonist
0,207  0,021  Antineoplastic antimetabolite
0,196  0,011  Antiviral (Influenza B)
0,191  0,007  Ornithine carbamoyltransferase inhibitor
0,320  0,138  Antiarthritic
0,252  0,072  Antiprotozoal (Leishmania)
0,186  0,006  MAP kinase kinase 1 inhibitor
0,238  0,058  Antiarrhythmic
0,199  0,021  Antineoplastic antibiotic
0,180  0,004  Hyperparathyroidism treatment
0,183  0,008  Tocolytic
0,207  0,032  ATPase inhibitor
0,182  0,007  Antileprosy
0,262  0,090  Hypoxia-inducible factor 1 alpha inhibitor
0,175  0,003  Vesicle monoamine transporter inhibitor
0,185  0,014  Alcohol dehydrogenase inhibitor
0,176  0,006  Phosphorylase inhibitor
0,214  0,044  Antihelmintic (Nematodes)
0,258  0,089  Antineoplastic (ovarian cancer)
0,171  0,002  Neuraminidase (Influenza A) inhibitor
0,210  0,043  VEGF expression inhibitor
0,177  0,012  Electrolyte absorption antagonist
0,169  0,004  Glucosylceramidase inhibitor
0,183  0,018  Protease inhibitor
0,232  0,067  Pyruvate kinase inhibitor
0,210  0,047  5 Hydroxytryptamine 3E antagonist
0,183  0,021  Sphingosine 1-phosphate receptor 5 antagonist
0,230  0,068  Cytotoxic
0,197  0,035  Cyclin-dependent kinase 3 inhibitor
0,168  0,009  Paget's disease treatment
0,287  0,128  Antineoplastic (myeloid leukemia)
0,181  0,024  MAP kinase kinase 4 inhibitor
0,273  0,115  Antineoplastic (endocrine cancer)
0,184  0,028  Cystathionine beta-synthase inhibitor
0,172  0,016  Porphobilinogen synthase inhibitor
0,175  0,020  Antiviral (CMV)
0,170  0,017  Arylamine N-Acetyltransferase substrate
0,171  0,019  Sphingosine 1-phosphate receptor 4 antagonist
0,185  0,033  DNA polymerase I inhibitor
0,156  0,004  Sphingosine 1-phosphate receptor 3 agonist
0,188  0,036  GABA C receptor rho-2 antagonist
0,177  0,025  Growth stimulant
0,180  0,029  Antiprotozoal (Trichomonas)
0,229  0,080  Angiogenesis stimulant
0,183  0,039  Antifungal enhancer
0,208  0,065  DNA methyltransferase I inhibitor
0,157  0,016  Antifungal (Pneumocystis)
0,164  0,025  Contraceptive female
0,175  0,035  Movement disorders treatment
0,156  0,017  NAD(P)H dehydrogenase (quinone) inhibitor
0,143  0,004  Antitreponemal
0,149  0,011  Antifungal (Candida)
0,198  0,061  Antianginal
0,214  0,077  Antineoplastic (glioblastoma multiforme)
0,141  0,004  Fumarate hydratase inhibitor
0,139  0,004  Antidote, organophosphates
0,157  0,022  Chronic obstructive bronchitis treatment
0,164  0,030  Coagulant
0,158  0,025  Antihelmintic (Fasciola)
0,199  0,067  Nitric oxide antagonist
0,166  0,035  Antibacterial (Helicobacter pylori)
0,140  0,010  Sphingosine 1-phosphate receptor 4 agonist
0,135  0,006  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,184  0,055  Antineoplastic (bone cancer)
0,150  0,021  DOPA decarboxylase inhibitor
0,164  0,037  Cyclooxygenase 3 inhibitor
0,138  0,012  Histone deacetylase SIRT1 stimulant
0,138  0,012  Histone deacetylase stimulant
0,203  0,077  DNA methylase inhibitor
0,187  0,062  Tumour necrosis factor antagonist
0,229  0,105  Antineoplastic (melanoma)
0,135  0,012  Toll-Like receptor 2 agonist
0,156  0,033  Sphingosine 1-phosphate receptor 2 antagonist
0,170  0,049  Antiprotozoal (Coccidial)
0,126  0,004  Epithelial sodium channel blocker
0,143  0,022  Anabolic
0,160  0,039  Adenylate cyclase inhibitor
0,150  0,029  UGT2B1 substrate
0,130  0,010  Glycine receptor agonist
0,128  0,011  Cathepsin D inhibitor
0,142  0,025  Calcium antagonist
0,131  0,016  Glutamate release inhibitor
0,160  0,045  Anesthetic local
0,191  0,076  Antiviral (Ebola)
0,128  0,014  Argininosuccinate synthase inhibitor
0,123  0,010  Anticholelithogenic
0,144  0,031  Sulfotransferase substrate
0,121  0,008  Endocannabinoid uptake inhibitor
0,138  0,026  Androgen antagonist
0,155  0,043  Cathepsin H inhibitor
0,119  0,008  GABA B receptor agonist
0,116  0,005  Sphingosine kinase inhibitor
0,129  0,019  Antifungal (Aspergillus)
0,129  0,018  Phosphodiesterase 6D inhibitor
0,131  0,021  Lanosterol 14 alpha demethylase inhibitor
0,145  0,037  Shock treatment
0,113  0,005  Prostaglandin agonist
0,189  0,080  Non-steroidal antiinflammatory agent
0,148  0,041  Vanilloid 1 agonist
0,124  0,019  Antiprotozoal activity enhancer
0,116  0,012  Estrogen-related receptor beta agonist
0,134  0,030  Prolactin inhibitor
0,110  0,006  Phosphoglycerate kinase inhibitor
0,142  0,040  SULT1A1 substrate
0,108  0,005  Renin inhibitor
0,143  0,041  Antiviral (Papilloma)
0,140  0,038  Choleretic
0,202  0,100  Urologic disorders treatment
0,201  0,100  Platelet antagonist
0,118  0,017  Na+ K+ transporting ATPase inhibitor
0,164  0,063  Phospholipase A2 inhibitor
0,165  0,065  Antianorexic
0,109  0,010  Antimycoplasmal
0,105  0,006  Sphingosine kinase 2 inhibitor
0,102  0,003  Sodium-dependent vitamin C transporter 2 inhibitor
0,107  0,008  Glutamate (mGluR6) antagonist
0,131  0,033  HIV-1 integrase (Overall Integration) inhibitor
0,137  0,040  Photosensitizer
0,106  0,009  Prostaglandin F2 alpha antagonist
0,139  0,042  Antiprotozoal (Babesia)
0,121  0,025  Ornithine decarboxylase inhibitor
0,127  0,031  Mental retardation treatment
0,146  0,050  Nav1.3 sodium channel blocker
0,100  0,005  Sphingosine 1-phosphate receptor agonist
0,147  0,052  Heat shock protein 70 antagonist
0,155  0,060  MAP kinase 3 inhibitor
0,149  0,055  Nav1.6 sodium channel blocker
0,108  0,014  Purinergic P2X1 antagonist
0,204  0,112  Neuropeptide Y2 antagonist
0,115  0,023  ATPase (Vacuolar H+) inhibitor
0,103  0,011  Interferon inducer
0,117  0,028  Antibiotic
0,150  0,060  MAP3K9 inhibitor
0,093  0,005  Sphingosine 1-phosphate receptor 1 agonist
0,111  0,023  Granulocyte macrophage colony stimulating factor agonist
0,098  0,010  Exportin-1 inhibitor
0,094  0,006  Adenosine deaminase inhibitor
0,103  0,015  Vanilloid 4 agonist
0,098  0,011  Antiviral (Herpesvirus 3, Human)
0,113  0,027  Glutathione S-transferase inhibitor
0,101  0,014  Beta 3 adrenoreceptor antagonist
0,129  0,043  Sphingosine 1-phosphate receptor 2 agonist
0,096  0,010  SULT2A1 substrate
0,119  0,033  Tourette's syndrome treatment
0,088  0,003  Prostaglandin EP2 agonist
0,103  0,019  Ribonucleoside-diphosphate reductase inhibitor
0,104  0,020  Ribonucleotide reductase inhibitor
0,098  0,014  MAP kinase kinase 7 inhibitor
0,102  0,019  Dysmenorrhea treatment
0,189  0,106  Free radical scavenger
0,086  0,005  Sphingosine kinase 1 inhibitor
0,092  0,010  MDM2 inhibitor
0,102  0,020  Sleep apnea treatment
0,090  0,009  Calcium channel P-type blocker
0,114  0,033  Antiviral (Rhinovirus)
0,144  0,064  Bone formation stimulant
0,152  0,072  CF transmembrane conductance regulator agonist
0,087  0,007  Lysophosphatidic acid 3 receptor antagonist
0,097  0,018  Beta adrenoreceptor antagonist
0,114  0,035  Actinic keratosis treatment
0,082  0,003  Uridine phosphorylase inhibitor
0,103  0,025  GABA aminotransferase inhibitor
0,120  0,043  Toll-Like receptor 4 antagonist
0,121  0,045  Anticataract
0,122  0,045  Carbonic anhydrase XV inhibitor
0,094  0,018  Phospholipase D inhibitor
0,131  0,057  Antiprotozoal (Amoeba)
0,119  0,045  Carbonic anhydrase III inhibitor
0,078  0,004  Cholesterol absorption inhibitor
0,078  0,004  Prostaglandin E2 agonist
0,095  0,021  Secretase beta inhibitor
0,086  0,014  Beta 1 adrenoreceptor antagonist
0,159  0,087  3C-like protease (Human coronavirus) inhibitor
0,105  0,034  Adrenaline agonist
0,074  0,004  Guanylate cyclase inhibitor
0,131  0,060  Gastritis treatment
0,075  0,005  Hypoxanthine phosphoribosyltransferase inhibitor
0,188  0,118  Heart failure treatment
0,099  0,029  NAT1 substrate
0,101  0,032  mTOR complex 2 inhibitor
0,091  0,022  Prostaglandin EP2 antagonist
0,072  0,003  Apical sodium codependent bile acid transporter inhibitor
0,179  0,113  Antineoplastic (glioma)
0,101  0,036  Xanthine oxidase substrate
0,104  0,039  ALK inhibitor
0,086  0,021  Gaucher disease treatment
0,074  0,010  Adenylate cyclase 1 inhibitor
0,073  0,010  Heparanase inhibitor
0,123  0,060  Monophenol monooxygenase inhibitor
0,133  0,070  Nav1.2 sodium channel blocker
0,073  0,010  Thymidine kinase inhibitor
0,117  0,055  Protein kinase C gamma inhibitor
0,069  0,007  GABA uptake inhibitor
0,099  0,038  Carbonic anhydrase XIII inhibitor
0,165  0,104  Psychostimulant
0,071  0,010  Immunoglobulin Fc receptor antagonist
0,116  0,056  Falcipain 3 inhibitor
0,065  0,005  Nucleoside transporters inhibitor
0,067  0,009  Dopamine beta hydroxylase inhibitor
0,072  0,015  Beta 2 adrenoreceptor antagonist
0,059  0,003  Lysophosphatidic acid receptor 1 agonist
0,073  0,018  Diacylglycerol O-acyltransferase inhibitor
0,212  0,157  Transcription factor NF kappa B inhibitor
0,064  0,010  Microtubule stabilization
0,072  0,019  Postcoital contraceptive
0,093  0,040  D-Ala-D-Ala ligase inhibitor
0,056  0,003  Ileal bile acid transport inhibitor
0,082  0,030  Female sexual dysfunction treatment
0,144  0,092  Growth hormone agonist
0,053  0,002  Lysophosphatidic acid receptor 3 agonist
0,068  0,017  Pregnane X receptor antagonist
0,087  0,037  Narcotic antagonist
0,065  0,014  Equilibrative nucleoside transport protein inhibitor
0,155  0,105  LDLR expression enhancer
0,148  0,099  Myocardial ischemia treatment
0,091  0,042  Glycine receptor antagonist
0,065  0,016  Squalene epoxidase inhibitor
0,054  0,005  Methionyl aminopeptidase 1 inhibitor
0,053  0,006  HMG CoA reductase inhibitor
0,052  0,004  Prostaglandin F2 alpha agonist
0,053  0,006  Sodium/glucose cotransporter 2 inhibitor
0,056  0,009  Glutamate (mGluR8) agonist
0,052  0,006  Methionyl aminopeptidase 2 inhibitor
0,077  0,031  Glutamate (mGluR7) antagonist
0,076  0,031  NMDA receptor glycine site agonist
0,191  0,147  Transcription factor STAT3 inhibitor
0,070  0,026  Sphingosine 1-phosphate receptor 3 antagonist
0,055  0,010  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,068  0,023  Beta 2 adrenoreceptor agonist
0,056  0,012  Membrane dipeptidase inhibitor
0,133  0,089  Cytidine deaminase inhibitor
0,078  0,033  Neutrophil collagenase inhibitor
0,058  0,015  Cytokine production stimulant
0,052  0,008  Lysophosphatidic acid 2 receptor antagonist
0,164  0,121  Transplant rejection treatment
0,053  0,011  Kainate receptor agonist
0,094  0,052  Aminoacyl-tRNA synthetase inhibitor
0,166  0,125  Antialcoholic
0,067  0,026  Protein 50S ribosomal subunit inhibitor
0,053  0,013  Arginase inhibitor
0,103  0,063  Nav1.1 sodium channel blocker
0,088  0,048  Carbonic anhydrase VI inhibitor
0,097  0,058  Potassium channel (Ca-activated) activator
0,108  0,069  Acetylcholine release stimulant
0,121  0,082  Sodium channel blocker
0,103  0,065  NAT2 substrate
0,072  0,034  Antihemophilic
0,078  0,040  S-adenosyl-L-methionine decarboxylase inhibitor
0,055  0,017  Geranyltranstransferase inhibitor
0,117  0,079  DNA repair enzyme inhibitor
0,042  0,005  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,050  0,013  Antibiotic Aminoglycoside-like
0,050  0,014  Heme oxygenase inhibitor
0,111  0,075  Interleukin 8 antagonist
0,052  0,016  Plasmepsin II inhibitor
0,079  0,043  Phosphodiesterase VI inhibitor
0,042  0,006  Sodium/glucose cotransporter inhibitor
0,061  0,026  Leukotriene C antagonist
0,118  0,083  Retinoprotector
0,040  0,005  Vitamin D receptor antagonist
0,040  0,005  Estrogen-related receptor gamma antagonist
0,051  0,016  Calcitonin receptor agonist
0,044  0,009  Lysine carboxypeptidase inhibitor
0,091  0,057  Phosphodiesterase I inhibitor
0,142  0,107  Hearing loss treatment
0,046  0,012  Vanilloid 3 antagonist
0,037  0,003  Neuraminidase (Influenza B) inhibitor
0,074  0,040  Protein kinase C beta inhibitor
0,073  0,039  Glucagon-like peptide 1 agonist
0,059  0,025  Bombesin 2 receptor antagonist
0,044  0,010  Cholesterol ester transfer protein antagonist
0,095  0,062  Bile acid receptor antagonist
0,064  0,031  Carbonic anhydrase VB inhibitor
0,043  0,011  Prostaglandin D2 agonist
0,195  0,164  AR expression inhibitor
0,068  0,037  NMDA receptor agonist
0,049  0,019  Beta adrenoreceptor agonist
0,040  0,010  Glutamate (mGluR3) agonist
0,036  0,006  Hedgehog signaling activator
0,054  0,024  Aldosterone antagonist
0,058  0,029  Sphingosine 1-phosphate receptor 5 agonist
0,038  0,008  Purinergic P2Y15 antagonist
0,063  0,035  Heat shock protein 90 beta antagonist
0,032  0,004  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,099  0,071  Topoisomerase I inhibitor
0,069  0,041  Leukotriene antagonist
0,059  0,031  Dihydroorotate oxidase inhibitor
0,042  0,014  Ceramide glucosyltransferase inhibitor
0,058  0,031  Leukotriene B4 antagonist
0,032  0,005  Isoleucine-tRNA ligase inhibitor
0,059  0,032  Sphingosine 1-phosphate receptor 1 antagonist
0,095  0,070  Glutamate (mGluR7) agonist
0,054  0,029  Antimetabolite
0,061  0,035  Ryanodine receptor antagonist
0,036  0,011  Purinergic P2T antagonist
0,029  0,004  Thromboxane A2 agonist
0,029  0,004  Carbonic anhydrase VIII inhibitor
0,029  0,004  Carbonic anhydrase X inhibitor
0,033  0,008  Sodium/glucose cotransporter 1 inhibitor
0,029  0,004  Sodium/hydrogen exchanger 3 inhibitor
0,039  0,014  ATP citrate lysase inhibitor
0,062  0,038  Cathepsin E inhibitor
0,042  0,019  VCAM-1 antagonist
0,037  0,014  Estrogen-related receptor beta antagonist
0,027  0,003  Methylmalonyl-CoA mutase inhibitor
0,042  0,019  VCAM antagonist
0,042  0,019  Glutamate (mGluR3) antagonist
0,030  0,007  Vesicular acetylcholine transporter inhibitor
0,038  0,015  GABA transporter 3 inhibitor
0,065  0,043  Protease 3C (Human rhinovirus) inhibitor
0,097  0,075  AMP-activated protein kinase stimulant
0,026  0,004  Antibiotic Anthracycline-like
0,032  0,010  Thymidine phosphorylase inhibitor
0,128  0,106  Pregnane X receptor agonist
0,142  0,122  Neurotensin receptor agonist
0,026  0,005  Vesicular glutamate transport inhibitor
0,067  0,047  Acetylcholine M5 receptor agonist
0,103  0,083  TRPA1 agonist
0,029  0,009  GRP78 expression inhibitor
0,024  0,005  Vitamin D receptor agonist
0,048  0,028  Purinergic P2Y antagonist
0,094  0,074  Gastric antisecretory
0,026  0,007  Excitatory amino acid transporter 3 inhibitor
0,043  0,024  Dopamine D5 agonist
0,058  0,039  Lipocortins synthesis agonist
0,051  0,032  Metalloproteinase-3 inhibitor
0,031  0,012  Calcium-sensing receptor agonist
0,023  0,005  Telomerase stimulant
0,025  0,007  Calcium-sensing receptor antagonist
0,065  0,047  Uterine relaxant
0,021  0,003  Purine nucleoside phosphorylase inhibitor
0,041  0,024  Vascular adhesion protein 1 inhibitor
0,048  0,031  Thymidylate synthase inhibitor
0,103  0,086  Caspase 3 inhibitor
0,031  0,015  MAP3K8 inhibitor
0,036  0,020  Sirtuin 2 inhibitor
0,146  0,129  Phobic disorders treatment
0,081  0,065  NMDA receptor antagonist
0,028  0,013  Vanilloid 2 agonist
0,086  0,071  Restless leg syndrome treatment
0,018  0,004  Thromboxane agonist
0,022  0,007  Adenosine A2 receptor agonist
0,039  0,026  Leukotriene C4 antagonist
0,054  0,040  Neuropeptide agonist
0,024  0,011  GABA transporter inhibitor
0,061  0,047  Nitric oxide donor
0,035  0,022  RNA-directed RNA polymerase inhibitor
0,057  0,045  Androgen agonist
0,026  0,014  Excitatory amino acid transporter 2 inhibitor
0,090  0,077  Insulin receptor antagonist
0,042  0,030  GABA B receptor antagonist
0,086  0,074  Protein kinase C zeta inhibitor
0,026  0,014  Glutamate (mGluR1) agonist
0,035  0,023  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,020  0,009  Prostacyclin agonist
0,024  0,013  ICAM 1 antagonist
0,018  0,008  Purinergic P2Y1 agonist
0,079  0,069  Antiviral (Dengue virus)
0,073  0,063  Sphingosine 1-phosphate receptor antagonist
0,114  0,104  Neurotrophic factor
0,020  0,010  Cyclin T1 inhibitor
0,019  0,009  Prostaglandin EP4 agonist
0,014  0,004  Excitatory amino acid transporter 4 inhibitor
0,061  0,051  Aryl hydrocarbon receptor antagonist
0,018  0,009  Adenosine A2a receptor agonist
0,071  0,061  Potassium channel (Tandem pore domain) blocker
0,016  0,008  GABA transporter 1 inhibitor
0,079  0,071  Transcription factor NF kappa B stimulant
0,027  0,020  LFA antagonist
0,023  0,015  Glutamate (mGluR1a) agonist
0,023  0,016  Beta 1 adrenoreceptor agonist
0,014  0,007  Glutamate (mGluR6) agonist
0,020  0,015  Retinoid X beta receptor antagonist
0,054  0,048  Cyclin-dependent kinase 6 inhibitor
0,053  0,048  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,038  0,034  Oxytocin agonist
0,041  0,037  AICAR transformylase inhibitor
0,062  0,057  Carbonic anhydrase VA inhibitor
0,022  0,018  Monocarboxylic acid transporter inhibitor
0,022  0,018  Monocarboxylic acid transporter 1 inhibitor
0,022  0,018  Aminopeptidase P inhibitor
0,045  0,041  Topoisomerase II beta inhibitor
0,037  0,034  Neurokinin 2 antagonist
0,031  0,028  Protein kinase (CK2) beta inhibitor
0,014  0,011  S-adenosyl-L-homocysteine hydrolase inhibitor
0,035  0,032  Retinoid X receptor antagonist
0,032  0,029  Retinoid X alpha receptor antagonist
0,034  0,031  Tryptophan 5 hydroxylase inhibitor
0,084  0,082  Xanthine oxidase inhibitor
0,031  0,029  Retinoid X receptor agonist
0,010  0,008  Purinergic P2Y2 agonist
0,033  0,032  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,036  0,035  Glutamate (mGluR1a) antagonist
0,021  0,020  Retinoic acid gamma receptor agonist
0,033  0,032  Farnesoid X receptor agonist
0,106  0,106  Cocaine dependence treatment
0,018  0,017  Hexokinase stimulant
0,015  0,015  Excitatory amino acid transporter 1 inhibitor
0,030  0,030  Retinoid X alpha receptor agonist
0,017  0,017  Estrogen-related receptor gamma agonist

